Brip1 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
BRIP1 (BRCA1-Interacting Protein 1) is a DNA helicase and nuclease that plays critical roles in DNA repair, specifically in the Fanconi anemia pathway and homologous recombination. Originally identified as an interacting partner of BRCA1, BRIP1 (also known as BACH1) is essential for maintaining genomic stability in proliferating cells, including neurons that are particularly vulnerable to DNA damage accumulation during aging.
| BRIP1 Protein |
| Protein Name | BRCA1-interacting protein 1 |
| Alternative Names | BACH1, FANCJ |
| Gene | BRIP1 |
| UniProt ID | Q9UQM7 |
| Chromosomal Location | 17q23.2 |
| Protein Class | DNA helicase (Superfamily 1) |
| Subcellular Localization | Nucleus (chromatin) |
| Protein Family | DEAH family DNA helicases |
| Molecular Weight | ~130 kDa |
BRIP1 contains several functional domains:
¶ N-terminal Domain
- BRCA1 BRCT domain binding region
- Phospho-Serine binding motif
- Mediates interaction with phosphorylated BRCA1
- DNA-binding domain
- Helicase core motifs (I-VI)
- ATP-dependent DNA helicase activity
¶ C-terminal Domain
- Iron-sulfur (Fe-S) cluster
- DNA nuclease activity
- Required for DNA binding and unwinding
BRIP1 (also known as FANCJ) is a key component of the Fanconi anemia (FA) pathway, which repairs interstrand crosslinks (ICLs):
- Core complex recruitment to DNA damage sites
- Unwinding of DNA structures during repair
- 5' to 3' helicase activity
- Coordination with other FANC proteins
- Works with BRCA1 in HR repair
- Processes DNA ends for recombination
- Resolves D-loops during strand invasion
- Maintains genome stability
- BACH1 originally identified as a transcriptional regulator
- May regulate oxidative stress response genes
- Interaction with BTB domain proteins
BRIP1 dysfunction may contribute to AD pathogenesis:
DNA Damage Accumulation:
- Impaired ICL repair in neurons
- Accumulation of unrepaired DNA damage
- Increased genomic instability in neurons
- Age-related decline in BRIP1 function
Neuronal Vulnerability:
- Post-mitotic neurons cannot dilute DNA damage through division
- Impaired DNA repair accelerates neurodegeneration
- Interactions with amyloid-beta and Tau pathology
Research Findings:
- BRIP1 expression altered in AD brain
- Reduced DNA repair capacity
- Association with early-onset AD
- Mitochondrial DNA repair involvement
- Vulnerability of dopaminergic neurons
- Oxidative stress and DNA damage
- Potential association with PD risk
- Biallelic BRIP1 mutations cause FA subtype (FANCJ)
- Severe bone marrow failure
- Developmental abnormalities
- Cancer predisposition
BRIP1 mutations increase cancer risk:
- Breast cancer (with BRCA1/2)
- Ovarian cancer
- Esophageal cancer
- Head and neck squamous cell carcinoma
Therapeutic Implications:
- PARP inhibitor sensitivity
- Synthetic lethality approaches
BRIP1 is expressed in various brain regions:
Expression is highest in proliferating cells but maintained in neurons for DNA repair functions.
- PARP inhibitors: BRIP1-deficient tumors sensitive
- Combination therapies: With BRCA1/2 targeting
- Synthetic lethality: Emerging therapeutic approaches
- Enhancing DNA repair capacity
- Gene therapy approaches
- Small molecule activators
The study of Brip1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Cantor et al., BACH1, a novel helicase (2001) - Cell
- Levitus et al., BRIP1/FANCJ mutations in Fanconi anemia (2005) - Nature Genetics
- Litman et al., BACH1/BRIP1 in breast cancer (2005) - Nature Genetics
- Bridge et al., BRIP1 helicase activity (2005) - JBC
- Peng et al., BRIP1 in neurodegeneration (2020) - Trends in Cell Biology
- Fouquerel et al., BRIP1 and DNA repair in AD (2019) - DNA Repair
- Cai et al., BRIP1 mutations in neurological disease (2019) - Brain
- Tadokoro et al., Chromatin recruitment of FANCJ (2021) - Nature